Management of patients with multiple myeloma and COVID-19 in the post pandemic era: a consensus paper from the European Myeloma Network (EMN)

E Terpos, P Musto, M Engelhardt, M Delforge, G Cook… - Leukemia, 2023 - nature.com
In the post-pandemic COVID-19 period, human activities have returned to normal and
COVID-19 cases are usually mild. However, patients with multiple myeloma (MM) present an …

First COVID-19 booster dose in the general population: a systematic review and meta-analysis of willingness and its predictors

P Galanis, I Vraka, A Katsiroumpa, O Siskou… - Vaccines, 2022 - mdpi.com
The emergence of breakthrough infections and new highly contagious variants of SARS-
CoV-2 threaten the immunization in individuals who had completed the primary COVID-19 …

Association of semaglutide with risk of suicidal ideation in a real-world cohort

W Wang, ND Volkow, NA Berger, PB Davis… - Nature medicine, 2024 - nature.com
Concerns over reports of suicidal ideation associated with semaglutide treatment, a
glucagon-like peptide 1 receptor (GLP1R) agonist medication for type 2 diabetes (T2DM) …

Association of COVID-19 with new-onset Alzheimer's disease

L Wang, PB Davis, ND Volkow… - Journal of …, 2022 - content.iospress.com
An infectious etiology of Alzheimer's disease has been postulated for decades. It remains
unknown whether SARS-CoV-2 viral infection is associated with increased risk for …

Breakthrough COVID-19 in vaccinated patients with hematologic malignancies: results from the EPICOVIDEHA survey

L Pagano, J Salmanton-García… - Blood, The Journal …, 2022 - ashpublications.org
Limited data are available on breakthrough COVID-19 in patients with hematologic
malignancy (HM) after anti–severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) …

Phase I/II trial of a peptide-based COVID-19 T-cell activator in patients with B-cell deficiency

JS Heitmann, C Tandler, M Marconato, A Nelde… - Nature …, 2023 - nature.com
T-cell immunity is central for control of COVID-19, particularly in patients incapable of
mounting antibody responses. CoVac-1 is a peptide-based T-cell activator composed of …

[HTML][HTML] Association of COVID-19 with respiratory syncytial virus (RSV) infections in children aged 0–5 years in the USA in 2022: a multicentre retrospective cohort …

L Wang, PB Davis, N Berger, DC Kaelber… - Family medicine and …, 2023 - ncbi.nlm.nih.gov
Objective To investigate whether COVID-19 infection was associated with increased risk for
incident respiratory syncytial virus (RSV) infections and associated diseases among young …

Association of COVID-19 with endocarditis in patients with cocaine or opioid use disorders in the US

L Wang, ND Volkow, NA Berger, PB Davis… - Molecular …, 2023 - nature.com
The incidence of endocarditis in the US is increasing, driven in part by the rise in
intravenous drug use, mostly opioids and stimulant drugs (cocaine and methamphetamine) …

Association of semaglutide with reduced incidence and relapse of cannabis use disorder in real-world populations: a retrospective cohort study

W Wang, ND Volkow, NA Berger, PB Davis… - Molecular …, 2024 - nature.com
Cannabis is the most frequently used illicit drug in the United States with more than 45
million users of whom one-third suffer from a cannabis use disorder (CUD). Despite its high …

Booster vaccination against SARS-CoV-2 induces potent immune responses in people with human immunodeficiency virus

S Fidler, J Fox, T Tipoe, S Longet… - Clinical Infectious …, 2023 - academic.oup.com
Background People with human immunodeficiency virus (HIV) on antiretroviral therapy
(ART) with good CD4 T-cell counts make effective immune responses following vaccination …